2015 Pricing Startup Study 
Both Sides of the Table
FEBRUARY 12, 2019
Round sizes of > $100 million or more now account for 47% of all VC dollars (62% if you count rounds > $50 million) This has made venture capital significantly more valuable for VCs and LPs who invest in the best companies As part of our study we noticed a trend many have spotted but few have explained?—?why
Startup Professionals Musings
DECEMBER 31, 2014
According to earlier studies from Forbes Insights , many entrepreneurs and small businesses not only feel the lessons learned during the past few years have helped them survive, but the recession also exposed flaws in their business strategies that they were able to fix. 2015 business optimism entrepreneur strategy' Marty Zwilling.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
OCTOBER 28, 2016
Two “triple” combination regimens for CF , which are meant to expand the reach of its CF drugs, will begin Phase 2 trials by the end of the year, and two additional new CF drugs will start clinical testing in 2017. THIS WEEK IN DRUG PRICING…. —A coalition of investors pressed drug makers to justify price increases.
Both Sides of the Table
JUNE 22, 2015
PR Malloy (@diddly_do_indy) June 13, 2015. Although the carriers made a lot of money initially by selling dial-up Internet services, customers never took their software because, well, it sucked. So the value on the Internet went “up the stack” to portals such as Yahoo!, Excite, MSN and eventually Google.
Tech Zulu Event
AUGUST 6, 2015
In the months and days leading up to its debut, Jet CEO and founder Marc Lore tried again and again to downplay the notion that his company would compete head-to-head with Amazon. On July 21, Jet’s launch day, Profitero conducted a study to evaluate Jet’s lowest-price promise. same UPC, brand, and size) across seven categories.
socalTECH
MAY 25, 2016
We caught up with Jim Armstrong to learn more about the new fund, areas of interest, his insights into what makes startups successful, and where he thinks the venture market is today. That's when you start meddling in the company. What is the investment focus for this fund? It's all about the entrepreneur.
Xconomy
SEPTEMBER 2, 2016
Just last month, a startup Tsien cofounded announced a round of funding to push ahead with a fluorescent technology that aims to help surgeons cut out tumors without removing healthy tissue. —Healthcare giant Novartis (NYSE: NOV ) is breaking up its cell and gene therapy R&D group , laying off roughly 30 percent of staff. .
Expert insights. Personalized for you.
328 
Let's personalize your content